Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 9Phase 1/2 5Phase NA 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 6Recurrence 2Lymphoma, Large B-Cell, Diffuse 2Leukemia 2Vomiting 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Nausea 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Leukemia, Biphenotypic, Acute 1Asthma 1

Interventions

Cyclophosphamide 17fludarabine phosphate 12Rituximab 12Peripheral Blood Stem Cell Transplantation 12Filgrastim 11Cyclosporine 11Whole-Body Irradiation 8Mycophenolic Acid 8Radiotherapy 7Busulfan 7Antilymphocyte Serum 7Vincristine 6Prednisone 6Melphalan 6Etoposide 6Methotrexate 5Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Therapeutics 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Cytarabine 3Carmustine 3Aprepitant 3Analgesia 3plerixafor 2Vindesine 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large B-Cell, Diffuse × Prednisolone × Clear all
NCT05990985 2023-08-18

The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

The First Hospital of Jilin University

Phase NA Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT00689845 2009-07-08

Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma

National Cancer Institute (NCI)

Phase NA Unknown
120 enrolled
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡